How to buy Invion shares
Own Invion shares in just a few minutes.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Invion Limited is a drug manufacturers-specialty & generic business based in Australia. Invion shares (IVX) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Invion has a trailing 12-month revenue of around $2.9 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Invion
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Invion . Find the share by name or ticker symbol: IVX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Invion reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Invion . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Invion share priceUse our graph to track the performance of IVX stocks over time.
Invion shares at a glance
|52-week range||$0.007 - $0.02|
|50-day moving average||$0.0115|
|200-day moving average||$0.0104|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.0002|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Invion stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Invion price performance over time
|1 week (2021-06-07)||6.25%|
|1 month (2021-05-14)||70.00%|
|3 months (2021-03-12)||88.89%|
|6 months (2020-12-14)||70.00%|
|1 year (2020-06-12)||112.50%|
|2 years (2019-06-14)||6.25%|
|3 years (2018-06-14)||-43.33%|
|5 years (2016-06-14)||261.70%|
|Revenue TTM||$2.9 million|
|Gross profit TTM||$1.9 million|
|Return on assets TTM||-8.69%|
|Return on equity TTM||-11.97%|
|Market capitalisation||$88.6 million|
TTM: trailing 12 months
Invion share dividends
We're not expecting Invion to pay a dividend over the next 12 months.
Invion share price volatility
Over the last 12 months, Invion 's shares have ranged in value from as little as $0.007 up to $0.02. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Invion 's is 1.9491. This would suggest that Invion 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Invion Limited, a clinical-stage life-sciences company, researches and develops photodynamic therapy for the treatment of various cancers in Australia. The company is developing IVX-PDT, a chlorophyll-based photosensitizer to treat skin cancers, as well as solid cancers, including lung, prostrate, ovarian, and mesothelioma cancers. It has a research and development agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company was incorporated in 2000 and is headquartered in Melbourne, Australia.
Frequently asked questions
More guides on Finder
How to buy Invion shares
Steps to owning and managing Regency Centers shares.
How to buy The Honest Company (HNST) shares from Australia
Here's everything we know so far about The Honest Company IPO and how to buy in from Australia.
How to buy Invion shares
Steps to owning and managing Applyflow shares.
Cheap gas providers in SA
Compare gas plans from South Australia providers. Find a better deal and switch today.
Best headphones in Australia
Our expert team of reviewers pick the best headphones in Australia, with a little help from real consumer reviews.
How to buy Marqeta stock from Australia when it goes public
Here's everything we know so far about the Marqeta IPO and how to buy in from Australia.
Kiwi broker Sharesies launches 1 cent ASX share trading in Australia
You can now invest as little as 1 cent into Australian, NZ and US shares. Here's why that's a game changer.
How to invest in the Didi Chuxing IPO from Australia
Everything we know about the Didi Chuxing IPO, plus information on how to buy in.
How to buy Robinhood stock from Australia
Robinhood is set to go public as soon as June. Here's what you need to do to buy in from Australia.
How to build a DIY Raspberry Pi arcade machine for retro gaming
We explain everything you need to make your own retro arcade machine, built around the super-flexible Raspberry Pi.
Ask an Expert